Molecular Targeted Therapy in Melanoma: A Way to Reverse Resistance to Conventional Drugs

Publisher： Bentham Science Publishers

E-ISSN： 1875-5704|9|1|17-29

ISSN： 1567-2018

Source： Current Drug Delivery, Vol.9, Iss.1, 2012-01, pp. : 17-29

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adipocytes Contribute to Resistance of Human Melanoma Cells to Chemotherapy and Targeted Therapy

By  

Current Medicinal Chemistry, Vol. 21, Iss. 10, 2014-04 ,pp. : 1255-1267

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular targeted therapy for patients with melanoma: the promise of MAPK pathway inhibition and beyond

By Sullivan Ryan J   Atkins Michael B  

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 10, 2010-10 ,pp. : 1205-1216

Informa Healthcare

Access to resources Recommend Favorite

Towards the Targeted Therapy of Melanoma

By  

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 4, 2006-04 ,pp. : 387-393

Bentham Science Publishers

Access to resources Recommend Favorite

The future of targeted therapy approaches in melanoma

By Cantini Liliana P   Meier Friedegund   Sondak Vernon K   Smalley Keiran SM  

Expert Opinion on Drug Discovery, Vol. 4, Iss. 4, 2009-04 ,pp. : 445-456

Informa Healthcare

Access to resources Recommend Favorite

Novel Protein Targeted Therapy of Metastatic Melanoma

By  

Current Pharmaceutical Design, Vol. 9, Iss. 25, 2003-10 ,pp. : 2060-2066

Bentham Science Publishers

Access to resources Recommend Favorite